Enhancing innovation and diversity in cancer clinical research
Official title: Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
Funded at New York University School of Medicine · NIH-10920461 · Data updated 2026-11-12
This study is all about making cancer research, especially for melanoma, better and more inclusive by encouraging new ideas, supporting young researchers, and ensuring that people from different backgrounds can join clinical trials, which could lead to better treatment options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 5, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $110,706 |
| NIH project number | 5R50CA282100-02 |
| Project ID | NIH-10920461 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation would include individuals diagnosed with melanoma or other skin cancers who are interested in contributing to clinical research.
✕Less likely to help
Patients with conditions unrelated to melanoma or cutaneous oncology may not receive direct benefits from this research.
What this research studies
This research focuses on fostering a culture of innovation, mentorship, and diversity within NCI-sponsored clinical research, particularly in the field of melanoma and cutaneous oncology. Led by Dr. Janice M. Mehnert, the project aims to improve clinical trial operations and enhance the participation of diverse populations in cancer research. The approach includes strategic planning, oversight of clinical trial activities, and mentoring junior investigators to ensure a robust pipeline of future researchers. Patients may benefit from improved access to clinical trials and more inclusive research practices.
Why it matters
Potential benefit: If successful, this research could lead to more effective and inclusive cancer treatments by ensuring diverse patient representation in clinical trials.
How similar studies have gone: Previous initiatives aimed at increasing diversity and mentorship in clinical research have shown positive outcomes, suggesting that this approach could also be effective.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Mehnert, Janice M. — New York University School of Medicine
- Study coordinator: Mehnert, Janice M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.